Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

2.3K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.3K
Inhaled Medications01:23

Inhaled Medications

1.1K
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.1K
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

804
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
804
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

212
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
212
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

368
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

1.3K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

From global guidelines for cardio-kidney-metabolic diseases management to national implementation: perspectives from the guideline workshop taskforce.

Cardiovascular diabetology·2026
Same author

Potential Applications of Inhaled Insulin in Diabetic Ketoacidosis Prevention and During Exercise: Two Case Presentations.

Diabetes technology & therapeutics·2026
Same author

Unmet Needs in Insulin-Treated Diabetes Management.

Diabetes technology & therapeutics·2026
Same author

Role of Ultra-Rapid Acting Insulin in Managing Diabetes.

Diabetes technology & therapeutics·2026
Same author

Automated Insulin Delivery Is Beneficial in Adults With Insulin-Treated Type 2 Diabetes With and Without GAD65 Antibodies.

Diabetes care·2025
Same author

Role of Continuous Dual Glucose-Ketone Monitoring in Diabetes Care.

Diabetes technology & therapeutics·2025

相关实验视频

Updated: May 3, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K

剂量 Afrezza: 这不是那么复杂.

Steve V Edelman1, Thomas C Blevins2, Christopher G Parkin3

  • 1University of California San Diego, San Diego, California, USA.

Diabetes technology & therapeutics
|February 1, 2026
PubMed
概括
此摘要是机器生成的。

阿弗雷扎吸入胰岛素有效地管理饭后血糖高峰. 尽管可用,但临床医生的意识有限和剂量混乱阻碍了其采用,需要为更广泛的使用提供实际指导.

关键词:
延迟低血糖症的时间低血糖症是一种低血糖症.吸入的胰岛素可以吸入.胰岛素的管理 胰岛素的管理胰岛素的剂量 胰岛素的剂量吃饭后的饮食方式第1类糖尿病 1型糖尿病2 型糖尿病 2 型糖尿病

更多相关视频

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

42.1K
Ammonia Fiber Expansion AFEX Pretreatment of Lignocellulosic Biomass
09:30

Ammonia Fiber Expansion AFEX Pretreatment of Lignocellulosic Biomass

Published on: April 18, 2020

15.4K

相关实验视频

Last Updated: May 3, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

42.1K
Ammonia Fiber Expansion AFEX Pretreatment of Lignocellulosic Biomass
09:30

Ammonia Fiber Expansion AFEX Pretreatment of Lignocellulosic Biomass

Published on: April 18, 2020

15.4K

科学领域:

  • 药理学 药理学 是一个学科.
  • 内分泌学 在内分泌学.
  • 糖尿病管理 糖尿病管理

背景情况:

  • 阿弗雷扎吸入胰岛素提供了传统皮下胰岛素输送的替代方案.
  • 它提供了餐后快速血糖控制,降低了延迟低血糖的风险.
  • 尽管在市场上已经有十多年的时间,但临床采用仍然有限.

研究的目的:

  • 为优化Afrezza利用提供专家观点.
  • 解决阻碍Afrezza广泛临床应用的障碍.
  • 提供关于Afrezza剂量,定位,患者选择和教育的实际指导.

主要方法:

  • 对Afrezza的临床数据和专家经验的审查.
  • 分析影响临床医生的意识和患者接受度的因素.
  • 为有效实施Afrezza制定实际战略.

主要成果:

  • 阿弗雷扎独特的药物动力学特征有助于食后血糖控制.
  • 关键障碍包括临床医生缺乏意识,剂量不确定性和安全性/有效性怀疑.
  • 清晰的剂量,定位和患者教育策略至关重要.

结论:

  • 阿弗雷扎是治疗食后高血糖症的宝贵工具.
  • 克服采用障碍需要加强临床医生的教育和简化实践指南.
  • 战略性患者选择和教育可以改善Afrezza的治疗结果.